de Haan RJ - Search Results

1

A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial.

Zinkstok SM, Vermeulen M, Stam J, de Haan RJ, Roos YB; ARTIS study group. Zinkstok SM, et al. Among authors: de haan rj. Trials. 2010 May 12;11:51. doi: 10.1186/1745-6215-11-51. Trials. 2010. PMID: 20459856 Free PMC article. Clinical Trial.

2

Impairment, disability, or handicap in peripheral neuropathy: analysis of the use of outcome measures in clinical trials in patients with peripheral neuropathies.

Molenaar DS, de Haan R, Vermeulen M. Molenaar DS, et al. J Neurol Neurosurg Psychiatry. 1995 Aug;59(2):165-9. doi: 10.1136/jnnp.59.2.165. J Neurol Neurosurg Psychiatry. 1995. PMID: 7629531 Free PMC article. Review.

3

Treatment outcomes in cervical dystonia: a clinimetric study.

Lindeboom R, de Haan RJ, Aramideh M, Brans JW, Speelman JD. Lindeboom R, et al. Among authors: de haan rj. Mov Disord. 1996 Jul;11(4):371-6. doi: 10.1002/mds.870110404. Mov Disord. 1996. PMID: 8813215 Review.

4

The role of cognitive impairment in the quality of life after ischaemic stroke.

Kwa VI, Limburg M, de Haan RJ. Kwa VI, et al. Among authors: de haan rj. J Neurol. 1996 Aug;243(8):599-604. doi: 10.1007/BF00900948. J Neurol. 1996. PMID: 8865027

5

Bleeding classification in clinical trials: observer variability and clinical relevance.

Graafsma YP, Prins MH, Lensing AW, de Haan RJ, Huisman MV, Büller HR. Graafsma YP, et al. Among authors: de haan rj. Thromb Haemost. 1997 Oct;78(4):1189-92. Thromb Haemost. 1997. PMID: 9364983

6

Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy.

Molenaar DS, Vermeulen M, de Haan R. Molenaar DS, et al. J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):84-9. doi: 10.1136/jnnp.64.1.84. J Neurol Neurosurg Psychiatry. 1998. PMID: 9436733 Free PMC article.

7

Treatment of cervical dystonia: a comparison of measures for outcome assessment.

Lindeboom R, Brans JW, Aramideh M, Speelman HD, De Haan RJ. Lindeboom R, et al. Among authors: de haan rj. Mov Disord. 1998 Jul;13(4):706-12. doi: 10.1002/mds.870130417. Mov Disord. 1998. PMID: 9686779

8

Impact of neurologic signs and symptoms on functional status in peripheral neuropathies.

Molenaar DS, Vermeulen M, de Visser M, de Haan R. Molenaar DS, et al. Neurology. 1999 Jan 1;52(1):151-6. doi: 10.1212/wnl.52.1.151. Neurology. 1999. PMID: 9921863

9

[Interferon beta-1b now also for the secondary progressive form of multiple sclerosis?].

de Haan RJ, Vermeulen M. de Haan RJ, et al. Ned Tijdschr Geneeskd. 1999 Apr 3;143(14):709-11. Ned Tijdschr Geneeskd. 1999. PMID: 10347623 Dutch.

10

[New therapies in neurology, but who benefits?].

Vermeulen M, de Haan RJ. Vermeulen M, et al. Among authors: de haan rj. Ned Tijdschr Geneeskd. 1999 Aug 28;143(35):1764-6. Ned Tijdschr Geneeskd. 1999. PMID: 10494326 Review. Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters